The independent source for health policy research, polling, and news.
1,801 - 1,820 of 15,240 Results
A restructuring of the Medicare drug benefit has wiped out big drug bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
While many Republican state lawmakers remain firmly against Medicaid expansion, some key leaders in holdout states are showing a willingness to reconsider. Public opinion, financial incentives, and widening health care needs make resistance harder.
A federal district court judge dismissed a lawsuit attempting to invalidate the Biden administration’s Medicare prescription-drug price negotiation program. But the suit turned on a technicality, and several more court challenges are in the pipeline. Meanwhile, health policy pops up in Super Bowl ads, as Congress approaches yet another funding deadline. Alice Miranda Ollstein of Politico, Lauren Weber of The Washington Post, and Rachel Cohrs of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week they think you should read, too.
After a decade of work, a Kentucky program launched to diagnose lung cancer earlier is beginning to change the prognosis for residents by catching tumors when they’re more treatable.
KFF Health News' Céline Gounder explains the "five-day rule" on covid safety, how guidelines and testing have evolved, and how best to protect yourself and others.
Nearly 2 million Medi-Cal enrollees, mainly people who are aged, disabled, or in long-term care, can now accumulate savings and property without limitations and still qualify for the state’s health insurance program for low-income residents. They join an additional roughly 12 million enrollees who already had no asset limits.
KFF Health News shares the crème de la crème of reader-submitted health policy valentines. Two of our favorites melted our hearts and inspired original illustrations.
Drug overdose deaths in California state prisons rebounded to near record levels last year, a big setback for corrections officials who thought they were on the right track with medication-assisted treatment efforts. Prison officials and attorneys representing prisoners blame fentanyl.
Medicare pays hospitals about double what it pays other providers for the same services. The hospital lobby is fighting hard to make sure a switch to "site-neutral payments” doesn't become law.
Lawmakers and regulators are trying to understand how AI is changing health care and how it should be regulated. The industry fears overreach.
Doctors, patients, and hospitals have railed for years about the prior authorization processes that health insurers use to decide whether they’ll pay for patients’ drugs or medical procedures. The Biden administration announced a crackdown in January, but some state lawmakers are looking to go further.
Resorting to crowdfunding to pay medical bills has become so routine, in some cases health professionals recommend it.
Recently, thousands of older Americans have been dying weekly of covid. But most Americans aren’t wearing masks in public, a move that could prevent infections. Many at-risk seniors aren’t getting antiviral therapies, and older adults in nursing homes aren’t getting vaccines. Why?
For the first time, a jury has convicted a parent of a school shooter of charges related to the child’s crime, finding a mother in Michigan guilty of involuntary manslaughter and possibly opening a new legal avenue for gun control advocates. Meanwhile, as the Supreme Court prepares to hear a case challenging the FDA’s approval of the abortion drug mifepristone, a medical publisher has retracted some of the journal studies that lower-court judges relied on in their decisions. Alice Miranda Ollstein of Politico, Sarah Karlin-Smith of the Pink Sheet, and Rachana Pradhan of KFF Health News join KFF Health News’ Julie Rovner to discuss these issues and more. Plus, for “extra credit,” the panelists suggest health policy stories they read this week that they think you should read, too.
The FDA’s recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
Cities are experimenting with new ways to meet the rapidly increasing demand for behavioral health crisis intervention, at a time when incidents of police shooting and killing people in mental health crisis have become painfully familiar.
© 2026 KFF